Ladder Bio

Ladder Therapeutics

The company develops synthetic ladder-shaped molecules for pharmaceutical organisations to enable the discovery and manufacture of targeted therapeutics and diagnostic tests.

Serna Bio

This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Biograil

This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.

Leash Bio

This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.